Skip to main content

Why are the billionaires always laughing?

Because they know the corporate media will never call bullshit on their bullshit.

Why are the billionaires laughing?

It’s easy to laugh when the corporate press treats you as a glorious success instead of the epitome of a broken social order. They laugh because they know the corporate media prefers to fawn over them rather than hold them to account.

Today, we ask you to support our nonprofit journalism because we are not impressed by billionaires flying into space, their corporations despoiling our health and planet, or their vast fortunes safely concealed in tax havens across the globe. We are not laughing.

We are hard at work digging out the truth. Please support this independent journalism today by donating to our critical Fall Campaign. We cannot do it without you. Thank you. -- Craig Brown, Co-founder

Support Our Work -- Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Every donation—large or small—helps us bring you the news that matters.

An employee of ALMO, one of the leading manufacturers of disposable syringes worldwide, works at the company's production facility in Bad Arolsen, Germany on December 15, 2020. (Photo: Ina Fassbender/AFP via Getty Images)

An employee of ALMO, one of the leading manufacturers of disposable syringes worldwide, works at the company's production facility in Bad Arolsen, Germany on December 15, 2020. (Photo: Ina Fassbender/AFP via Getty Images)

Report Debunks Big Pharma's 'Dangerous Narrative' on Vaccine Supplies

"We need urgent public manufacturing and technology sharing to meet global need and end the pandemic."

Kenny Stancil

As an artificially low supply of Covid-19 vaccines prolongs the global pandemic, opponents of intellectual property waivers and other measures aimed at increasing the worldwide production of doses are claiming that pharmaceutical corporations are capable of quickly rectifying shortages on their own.

"Pharmaceutical companies have a financial interest in exaggerating their ability to deliver and downplaying the risks."
—Peter Maybarduk, Public Citizen

According to a new analysis published Thursday by advocacy group Public Citizen, however, this "dangerous narrative"—peddled by Big Pharma and based on "unrealistic" manufacturing projections—undermines efforts to develop and implement the ambitious policies necessary to expand the production of life-saving vaccines and bring the greatest public health crisis in a century to an end.

"People suffering and waiting for vaccines worldwide cannot afford for leaders to embrace wildly optimistic forecasts suggesting Covid-19 doses soon will be available," Peter Maybarduk, director of Public Citizen's Access to Medicines program, said in a statement. "We need urgent public manufacturing and technology sharing to meet global need and end the pandemic."

Prior to U.S. President Joe Biden's surprise endorsement last week of the India and South Africa-led motion at the World Trade Organization (WTO) to suspend coronavirus-related intellectual property barriers for the duration of the pandemic, the Pharmaceutical Research and Manufacturers of America (PhRMA) wrote the White House in an attempt to dissuade Biden from supporting the proposal, which is now backed by nearly every country outside of the European Union

In their letter (pdf), the industry lobbyists claimed that "Covid-19 vaccine manufacturers will supply approximately 10 billion doses by the end of 2021, enough to vaccinate the entire current global vaccine eligible population."

Although PhRMA failed to prevent Biden from embracing the movement for a vaccine patent waiver, Public Citizen warned Thursday that the emerging narrative that "the supply problem will soon be resolved" is still being "weaponized against structural reforms aimed at expanding supply." At the WTO, where decisions are made by consensus, any one of the body's 164 member nations can thwart the will of the supermajority. 

"Pharmaceutical companies have a financial interest in exaggerating their ability to deliver and downplaying the risks," Maybarduk explained. 

Meanwhile, COVAX—the United Nations-backed program to allocate vaccines to low- and middle-income countries, which health justice advocates have accused rich donor countries of hiding behind while they oppose the WTO patent waiver as well as C-TAP, the World Health Organization's voluntary technology transfer program—had shipped less than 50 million doses by the end of April, roughly one-fifth of its projected target of 235 million jabs.

Public Citizen argued in its analysis that the pharmaceutical industry's rosy outlook on global vaccine supply recklessly subverts attempts to develop and implement a truly viable program for boosting production while failing to account for the following six factors:

  1. Some vaccines may not be widely authorized by stringent regulatory authorities;
  2. Existing manufacturers may not be able to rapidly scale-up due to production errors and other delays, including shortages of raw materials;
  3. Boosters may fuel additional demand;
  4. Variants may render some current vaccines ineffective;
  5. Countries may stockpile doses; and
  6. Even if 10 billion doses are produced and distributed equitably, it may not be enough.

According to Public Citizen, "even if none of the risks identified above materialize... vaccinating the world will require 12 billion doses" assuming 80% of the global population needs to be inoculated.

 "Crossing our fingers is not a sustainable public health strategy."
—Zain Rizvi, Public Citizen

"The global response to ending the pandemic cannot be based on the most optimistic assumptions," said Zain Rizvi, law and policy researcher at Public Citizen and author of the analysis. "Crossing our fingers is not a sustainable public health strategy."

Instead of relying on a handful of private companies to rapidly produce billions of doses, a coalition of more than 60 groups, led by Public Citizen, recently urged Biden to immediately launch a global vaccine manufacturing program, as Common Dreams reported last month.

Public Citizen estimates that with "a whole-of-government effort to share technology, source raw materials, and provide technical assistance... the U.S. government can help rapidly produce 8 billion doses of mRNA vaccine for $25 billion."

"A waiver on intellectual property can further help remove obstacles to production," Rizvi noted. "The unprecedented global crisis demands an all-hands-on-deck response."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

In Face of Planetary Emergency, US Climate-Related Financial Risk Report Denounced as 'Pitiful' Failure

"Finding consensus between those who see or don't see our climate reality," said one critic, "is not democracy in action: it's homicidal."

Jon Queally ·


Schumer Endorses 'Inspiring Community Leader' India Walton as Buffalo's Next Mayor

The U.S. Senate majority leader's move comes as some key New York Democrats refuse to back the democratic socialist.

Jessica Corbett ·


'Who Will You Throw Overboard?' Manchin Targeted for Trying to Sink Democratic Agenda

West Virginians gathered at the senator's yacht to demand that he stop blocking the "popular and needed" Build Back Better package.

Jessica Corbett ·


'We Shouldn't Do It at All': Manchin Admits He's the Enemy of Democrats' Ambitions

The right-wing West Virginia Democrat and fossil fuel investor has previously confessed his intent to quash his own party's sweeping $3.5 trillion Build Back Better package.

Brett Wilkins ·


After Getting 'Stealth Bailout' During Pandemic, US Corporations Try to Kill Proposed Tax Hikes

"When it's time to finally put workers first, big businesses are spending millions to maintain their advantage and preserve the status quo," said Kyle Herrig of Accountable.US.

Jessica Corbett ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo